| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |